Imatinib radiosensitizes bladder cancer by targeting homologous recombination. (Cancer research, 2013)

(untitled) - Qiao, B; Kerr, M; Groselj, B; Teo, M; Knowles, M; Bristow, R; Phillips, R; Kiltie, A